Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological ...
In 2026, China's pharmaceutical export sector is poised for significant expansion, building on 2025's record-breaking out-licensing deals and a surge in innovative therapies. As the world's ...
4don MSN
AstraZeneca strikes deal for up to $18.5 billion to license weight-loss drugs from China's CSPC
By Andrew Silver SHANGHAI, Jan 30 (Reuters) - AstraZeneca will license experimental drugs for obesity and weight-related ...
SINGAPORE, Jan. 5, 2026 /PRNewswire/ -- Hyphens Pharma International Limited ("Hyphens Pharma", or the "Company", and together with its subsidiaries, the "Group"), Singapore's leading specialty ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...
The MarketWatch News Department was not involved in the creation of this content. SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results